The a2 Milk Company Limited reported robust performance for the first half of FY26, with revenue up 18.8% year-over-year to NZ$993.5 million. Growth was propelled by strong performances across all segments, notably in the China & Other Asia segment with a 20.3% revenue increase, and the USA segment up 29.1%. The company's strategy included significant investments such as acquiring a manufacturing facility in Pokeno, enhancing their supply chain capabilities. With a positive outlook for FY26, the company expects continued revenue growth and a stable EBITDA margin. Additionally, the company announced an interim dividend along with a planned special dividend, reflecting a strong financial position.
Key Points
The a2 Milk Company announced strong financial and operational results for the first half of the 2026 financial year, ending 31 December 2025.
Revenue grew by 18.8% to NZ$993.5 million compared to the prior year.
EBITDA increased by 18.4% to NZ$155 million, with underlying EBITDA up 25.9% to NZ$164.8 million.
Net profit after tax (NPAT) rose by 9.4% to NZ$112.1 million.
China & Other Asia segment saw a revenue increase of 20.3%, driven by growth in English label Infant Milk Formula (IMF) and Other Nutritionals.
Australian and New Zealand segment revenue grew by 8.8%, with significant growth in the Australian liquid milk sector.
USA segment sales were up 29.1%, driven by growth in core and Grassfed liquid milk products.
A significant acquisition was the purchase of a nutritional manufacturing facility in Pokeno, which was integral to the company's supply chain transformation.
The company announced an interim dividend of 11.5 cents per share and plans for a $300 million special dividend.
FY26 outlook anticipates mid double-digit revenue growth and an EBITDA margin of 15.5% to 16.0%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.